LINACS
LINACS Home
OligoCare
Group

BiTE

The data below refer to patients treated with BiTE as the sole drug class, excluding any concurrent use of drugs from other groups.
Individual Drugs

Select a drug to view its individual evidence base (drug + SBRT, no other concurrent systemic drugs). Drugs without available data are shown greyed out.

Tarlatamab
Catumaxomab
No data
Tebentafusp
No data